Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases

NCT01884311 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Primary Immune Deficiency Disorders
Common Variable Immunodeficiency
X-linked Agammaglobulinaemia
Hyperimmunoglobulin M Syndrome

Interventions

BIOLOGICAL: Subgam

Sponsor

Bio Products Laboratory